文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 外语学习 > 英语学习 > Molecular diagnosis and therapy of hepatocellularcarcinoma
侵权投诉

Molecular diagnosis and therapy of hepatocellularcarcinoma

科研文献,多多交流

JOURNALOFHEPATOLOGY

Furthermore,MicroRNAsareaclassofepigeneticallyactiveogenesisoflivercancer.Deregulationofthesignalingwasfre-smallregulatoryRNAsthatfunctiontomodulateproteinexpres-quentlyobservedinprimaryhumanlivercancerspecimensandsion[73].Thiscontrolallowsfor ne-tuningofthecellularphe-associatedwithdifferentotherrelevantpathways(e.g.,IGFandnotype,includingregulationofproliferation,cellsignaling,andEGF).Speci cinhibitorandRNAimediatedblockadeofthesignal-apoptosis.ingreducedtheproliferationofcancercellsinvitroandinvivo,AberrantexpressionsofMicroRNAsconsiderablycontributetoindicatingthepotentialfortargetingthemTORpathwayinHCCcancerinitiation,propagation,andprogression.Emergingevi-[91].denceindicatesthatcertainMicroRNAsarefrequentlyderegu-OtherexamplesstemfromagroupattheNCI.TheauthorslatedinHCC,andthatsomespeci cMicroRNAsareassociatedmadeuseofidenti edtargetsfromprognosticgeneexpressionwiththeclinicopathologicalfeaturesofHCC[74].ThesestudiessignaturesforthetreatmentofHCC.Usingwholegenomicanal-demonstratedthatMircoRNAshaveessentialrolesinHCCpro-yses,thegrouppreviouslyidenti edCOP1andCSN5astwocrit-gressionbydirectlycontributingtocellproliferation,apoptosis,icalregulatorsofp53activityviaproteasome-dependentandmetastasisofHCCandbytargetingalargenumberofcriticaldegradationinascreenforsurvivalgenesinhumanHCCprotein-codinggenesinvolvedinhepatocarcinogenesis[75].Not[15,46].Subsequently,Leeetal.successfullydemonstratedthatsurprising,thatMicroRNAsarealsoassociatedwiththeregula-targetingofbothgenescanprovidenoveltherapeuticmodalitiestionofliverCSC[76–78].againstlivercancercellsinvitro.RNAimediatedsilencingofeachInlivercarcinogenesis,MicroRNAshavebeenfoundtohavegene,inhibitedproliferationofHCCcellsandincreasedapoptoticbothtumorsuppressive(miR-122,miR-26,miR-223,Let-7fam-celldeaththroughtherestorationofp53function.Theauthorsily)andoncogenicactivity(miR-221,miR-222,Mir-224,Mir-9,furtherutilizedasystemicdeliveryofthemodi edtargetsiRNAsandMir-181).ForsomeMicroRNAs(e.g.,miR-221,miR-125B,bystable-nucleic-acid-lipid-particles(SNALP)andcon rmedmiR-26,miR-122)aprognosticrelevanceandpredictionofdrugremarkablesuppressionofmalignantgrowthandincreasedsur-sensitivity(e.g.,interferon)couldbedemonstrated[29,79–81].vivalinanorthotopicxenograftmousemodelwithoutelicitingInthelastyears,thepowerofMicroRNApro lingforclassi -overtimmuneresponse.Further,analysisofCOP1knockdowncationoflivercancershasbeendemonstrated.MicroRNApro lessignaturerevealedthattheanti-tumoreffectinvivowasdrivenrevealedsubclassesassociatedwithhistologicandetiologicfac-byp53-dependentapoptosis[51,52].Together,thesestudiessug-tors,clinicalphenotypesaswellasmutationsinseveralonco-gestthatsystemicanalysesofgeneexpressiondatacanprovidegenicpathwayssuchasb-CateninandHNF1A[82].Recently,animportantnewsteptowardspotentialclinicalapplicationinMicroRNApro lingof89HCCsamplesusingaligation-mediatedpersonalizedmedicine.ampli cationmethodrevealedthreedistinctclustersofHCCsTargetingofepigeneticmodi cationsprovidesanexcitingre ectingtheclinicalbehaviorofthetumors.Thefunctionalrolenew eldfortherapeuticstrategiesinHCC.Epigeneticchangesofdifferentidenti edMicroRNAsinparticularofthemiR-517arereversiblebydifferenttherapeuticdrugsleadingtore-activa-familywasfurtherinvestigatedincelllinesandinanorthotopictionofsilencedgenes.Demethylatingagentslike5-azacytidineasmousemodeloflivercancer.Asaresult,theauthorscouldasso-wellasHDACinhibitorssuchasvirinostatandvalproicacidareciatetheseMicroRNAswithincreasedproliferation,migration,alreadyapprovedforthetreatmentofhematologiccancersandandinvasionofHCCcellsinvitroandinvivo,indicatingthether-focusofmanyclinicalstudiesinsolidcancers(doc.guandang.net[83].als.gov)[29].NoveltechnologiessuchasnextgenerationsequencingwillRecently,theindividualdrug-responseofHCCcelllinestothelikelycontributetoamoredetailedunderstandingoftheroleDNAmethylationinhibitorzebularinecouldbedemonstratedofthisinterestingclassofmoleculesinhepatocarcinogenesis[49].Usingtranscriptomicandepigenomicpro ling,adrug

[84,85].responsesignaturecouldbegeneratedthatclassi edlivercancer

cellsaccordingtotheircorrespondingsensitivity.Indrug-sensi-tivecelllines,epigeneticmodulationcausedcellcyclearrest

TherapeutictranslationandtargettherapeuticsinHCCandincreasedapoptosis,whereasdrug-resistantcelllines

showedup-regulationofdominantoncogenicnetworks(for

Aberrantactivationofdifferentsignalingpathwayshasbeenfre-example,E2F1,MYC,andTNF).Therapeuticef ciencyagainstquentlydemonstratedinseveralsolidtumorsandraisedsubstan-sensitivecancercellswasfurtherrevealedinvivo,leadingtotialinterestfortranslationalresearchalsoforlivercancer[86,87].increasedsurvivalanddecreasedpulmonarymetastasis.Subse-Highlightingthesuccessofmulti-tyrosinkinaseinhibitorsorafe-quentintegrationofthegeneratedgeneexpressionanddemeth-nibthemajoraffectedsignalingpathwaysdysregulatedinliverylationresponsesignaturesalloweddifferentiationofpatientscancerareinvolvedincellularfunctions,suchasproliferationwithHCCaccordingtotheirclinicaloutcome.Thestudyprovided(e.g.,EGF,IGF,HGF,RAS/mitogen-activatedproteinkinase),apop- rstinsightsintopredictionoftreatmentsuccessagainstepige-tosisandsurvival(e.g.,Akt,Nf-Kb),angiogenesis,etc.(e.g.,VEGF,neticchemotherapyanddemonstratesthepowerofthephar-PDGF)(Table1)[7,9,20,47,88].Geneexpressionanalysescouldmaco-epigenomicapproachestoidentifycancerpatientswhorecapitulatemostofthesepathwaysandassociatethemwithlikelybene tfromtargetingthecancerepigenome.molecularandprognosticsubclasses[89,90].

Theef ciencyofwholegenomicapproachesfortheidenti ca-tionofnewmoleculartargetsandthedevelopmentofpathway-NovelcellulartargetsinHCC:aroleforhepaticCancerStemorientatedtreatmentstrategieshasbeensuccessfullyappliedinCellsdifferentstudies.Usinganintegrationalapproachofgenomicandtranscriptomicaswellasproteinlevels,Villaneuvaetal.ThehierarchicmodelofcanceroriginisbasedontheassumptioncoulddemonstratetheimportanceofmTORsignalinginthepath-thattumorheterogeneityoriginatesfromasmallpopulationof

Molecular diagnosis and therapy of hepatocellularcarcinoma

Molecular diagnosis and therapy of hepatocellularcarcinoma

so

JournalofHepatology2012vol.56j267–275271

上一页第5页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email